![Uma Mahesh Babu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Uma Mahesh Babu
Keine laufenden Positionen mehr
Profil
Uma Mahesh Babu worked as a Director of Research at Johnson & Johnson and as a Research Director at Chemtrak, Inc. He also worked as a Principal at Thomas Jefferson University and as a Vice President-Technology & Product Development at Rapid Pathogen Screening, Inc. Dr. Babu holds a doctorate degree from the University of Nebraska.
Ehemalige bekannte Positionen von Uma Mahesh Babu
Unternehmen | Position | Ende |
---|---|---|
JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | - |
Thomas Jefferson University | Corporate Officer/Principal | - |
CHEMTRAK INC. | Corporate Officer/Principal | - |
Rapid Pathogen Screening, Inc.
![]() Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Uma Mahesh Babu
University of Nebraska | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 2 |
---|---|
Rapid Pathogen Screening, Inc.
![]() Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Health Services |
Chemtrak, Inc.
![]() Chemtrak, Inc. Medical SpecialtiesHealth Technology Chemtrak, Inc. is a medical communications company dedicated to provide concise and timely medical information to healthcare industry professionals. The company was founded by Jerry B. Gin, Pyare Khanna and Prithipal Singh in 1985 and is headquartered in Huntington Station, NY. | Health Technology |